NewAmsterdam Pharma Company NV宣布,公司已根据纳斯达克上市规则5635(C)(4)的规定,报告了近期授予的激励性股票。此项授予符合相关监管要求,旨在激励员工并为公司长期发展注入动力。
NewAmsterdam Pharma Company NV宣布,公司已根据纳斯达克上市规则5635(C)(4)的规定,报告了近期授予的激励性股票。此项授予符合相关监管要求,旨在激励员工并为公司长期发展注入动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.